Publications by authors named "Sasai Tadashi"

Objective: The purpose of this study was to compare images generated by a multiple-echo recombined gradient echo (MERGE) with the proton density-weighted fast spin-echo (PD-weighted FSE) sequence, T1-weighted fast spin-echo sequence (T1-weighted FSE), and T2-weighted fast spin-echo sequence (T2-weighted FSE) for the diagnostic imaging of the temporomandibular joint (TMJ).

Materials And Methods: Twenty-three patients with signs and symptoms of TMJ dysfunction were enrolled in this study. The four imaging modalities were used to examine the TMJ.

View Article and Find Full Text PDF

Objectives: Oral cancer is the eighth most common type of cancer worldwide and a significant contributor to the global burden caused by this disease. The principal parameters considered to influence prognosis, and thus treatment selection, are size and location of the primary tumor, as well as assessment of the presence and extent of lymph node and distant metastasis (DM). However, no known report regarding the relationship between the primary site and DM has been presented.

View Article and Find Full Text PDF

Objective: The purpose of this study is to evaluate the corrections of signal intensity of the temporomandibular joint (TMJ) disc caused by variations in sensitivity of the magnetic resonance imaging (MRI) surface coil, to compare the modified signal intensities of the posterior and anterior bands, and then to evaluate the relationship of the signal intensity difference to altered disc position and morphology in a group of TMJ patients.

Study Design: MRI was performed on 96 joints. All patients underwent imaging in axial, coronal, and sagittal planes using fast-spin echo sequences (FSE).

View Article and Find Full Text PDF

This randomized controlled clinical trial was designed to compare the safety and effectiveness of different sequences of treatment with cisplatin (CDDP) and 5-fluorouracil (5-FU) in patients with unresectable advanced and post-operative recurrent gastric cancer. Patients with unresectable advanced or post-operative recurrent gastric cancer were randomly assigned by a registration center to group A or B. Group A received CDDP (80 mg/m(2)) as a continuous 2-h intravenous infusion on day 1 and 5-FU (700 mg/m(2)) as a continuous intravenous infusion on days 2-5.

View Article and Find Full Text PDF